CoreCap Advisors’s Medline Inc MDLN Stock Holding History

CoreCap Advisors’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$139	Buy	+4	New	+$146	﹤0.01%	3015

Other funds holding MDLN

Egerton Capital (UK) London, United Kingdom $9.8B AUM 22.76% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.31B AUM 25.55% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Clio Asset Management Charlottesville, Virginia $119M AUM 1.1% 1-Year Est. Return

Washington Trust Advisors Wellesley, Massachusetts $1.4B AUM 26.88% 1-Year Est. Return

Meiji Yasuda America New York $764M AUM 38.12% 1-Year Est. Return

CoreCap Advisors's MDLN Position: Q3 2026 in Review

CoreCap Advisors opened a new position in Medline Inc (MDLN) in Q3 2026: 4 shares worth $139. The stake represents ﹤0.01% of the portfolio and ranks #3015 among its holdings.

65 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

CoreCap Advisors held 4 shares of Medline Inc worth $139 as of Q3 2026.
Medline Inc was a new CoreCap Advisors position in Q3 2026.
Medline Inc made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #3015 holding.
65 funds tracked by Wall St. Rank held Medline Inc as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.